FindTrial
Sign In

A Study on effectiveness of the siddha medicine Singi Chunnam for Calcaneal Spur

An open clinical trial to evaluate the effectiveness of siddha formulation Singi Chunnam in the management of Kuthikaal Vatham (calcaneal spur) among outpatients attending Ayothidoss Pandithar Hospital,National institute of Siddha,Chennai-47 - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107782
Enrollment
30
Registered
2026-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M773- Calcaneal spur

Interventions

Intervention1: SINGI CHUNNAM: Siddha formulation to treat kuthikaal vatham (calcaneal spur) advised to take 100 mg with ghee once a day for 75 days (drug interval of 7 days and medicine for 7 days) C

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with complaint of pain in heel region Patient with Foot function index greater or equal to 50

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Patients with current history of uncontrolled diabetes mellitus HbA1c level of greater than 8 percent Those who received injection therapy like corticosteroids to the foot area in the last 3 months History of trauma or fracture over heel region History of surgery over the heel region

Design outcomes

Primary

MeasureTime frame
Improvement of Foot Function Index from moderate to mild impairment.Timepoint: 75 days—

Secondary

MeasureTime frame
There maybe pain reduction over heel region and improvement in quality of life.Timepoint: 75 days—

Countries

India

Contacts

Public ContactDr H Vetha Merlin Kumari

National Institute of Siddha

dr.vetha@gmail.com9894782366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026